|Articles|May 12, 2003

Hatcher to Lead Business Development Efforts for Ansell, Acute Care

RED BANK, N.J. -- Donna Hatcher has been named business development manager of acute care for Ansell Professional Healthcare. She will be responsible for coordinating market-related activities associated with Ansell's professional product lines, with an emphasis on planning and supporting the marketing and sales program.

Hatcher comes to Ansell from Boston Scientific, where she served as group product manager of endourology marketing. Prior to joining Boston Scientific, she was product director of global product management, cardiology, with Cordis, a Johnson & Johnson Company.

"With 10 years of progressive product marketing, communications and market research experience, Hatcher brings to Ansell an impressive background in international medical device products, managed care and medical education," said Bill Reed, senior vice president and regional director, Ansell Americas.

Hatcher is a graduate of Ohio University, where she earned a master's degree in business administration. She also holds bachelor's and master's degrees in fine arts and human nutrition from Ohio University.


Related to this article

Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
A brightly lit Hospital operating room, a surgical team wearing gowns and masks.  (Adobe Stock 1790696595 by Damian)
Turnover pressure can leave critical OR cleaning steps unfinished. Karen deKay, MSN, RN, EBP-C, CNOR, CIC, FAPIC, examines common gaps in environmental hygiene and how shared responsibilities, attention to disinfectant contact time, and ongoing education can help teams strengthen practices between cases.
Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.